
Page#1
Financial Statements
Condensed Consolidated Statements of Earnings
Years ended June 30
2017 2016 2015
Dollars in millions, except share and per share data 
Net sales $ 5,973 $ 5,761  $ 5,655
Cost of products sold  3,302  3,163 3,190 
Gross profit  2,671 2,598  2,465 
Selling and administrative expenses  810 806 798
Advertising costs 599 587 523
Research and development costs 135 141 136
Interest expense 88 88 100 
Other (income) expense, net 6 (7) (13)
Earnings from continuing operations before income taxes  1,033 983 921
Income taxes on continuing operations 330 335 315 
Earnings from continuing operations 703 648 606
Losses from discontinued operations, net of tax  (2) — (26)
Net earnings $ 701  $  648  $  580
Net earnings (losses) per share
 Basic
  Continuing operations  $ 5.45  $ 5.01  $  4.65 
  Discontinued operations (0.02)  — (0.20)
 Basic net earnings per share $ 5.43  $  5.01 $  4.45 
 Diluted
  Continuing operations $  5.35  $ 4.92  $  4.57
  Discontinued operations  (0.02)  — (0.20)
 Diluted net earnings per share $  5.33  $ 4.92  $  4.37
Weighted average shares outstanding (in thousands)
 Basic 128,953  129,472 130,310
 Diluted  131,566  131,717  132,776
 46  The Clorox Company 2017 Integrated Annual Report
Page#2
Financial Statements
Condensed Consolidated Balance Sheets
Years ended June 30
2017 2016
Dollars in millions, except share and per share data 
ASSETS 
Current assets
 Cash and cash equivalents $ 418 $ 401
 Receivables, net 565  569
 Inventories, net 459  443
 Prepaid expenses and other current assets 72  72
  Total current assets 1,514  1,485
Property, plant and equipment, net 931  906
Goodwill 1,196  1,197
Trademarks, net 654  657
Other intangible assets, net 68  78
Other assets 210  187
Total assets $ 4,573 $ 4,510
LIABILITIES AND STOCKHOLDERS’ EQUITY 
Current liabilities
 Notes and loans payable $ 404 $ 523
 Current maturities of long-term debt 400  —
 Accounts payable and accrued liabilities 1,005  1,035
 Income taxes payable —  —
  Total current liabilities 1,809  1,558
Long-term debt 1,391  1,789
Other liabilities 770  784
Deferred income taxes 61  82
  Total liabilities 4,031  4,213
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding —  —
Common stock: $1.00 par value; 750,000,000 shares authorized; 158,741,461 shares issued 
 as of June 30, 2017 and 2016; and 129,014,172 and 129,355,263 shares outstanding as of 
 June 30, 2017 and 2016, respectively 159  159
Additional paid-in capital 928  868
Retained earnings 2,440  2,163
Treasury shares, at cost: 29,727,289 and 29,386,198 shares as of June 30, 2017 and 2016, respectively  (2,442)  (2,323)
Accumulated other comprehensive net (losses) income (543) (570)
Stockholders’ equity 542  297
Total liabilities and stockholders’ equity $ 4,573 $ 4,510
 48  The Clorox Company 2017 Integrated Annual Report
Page#3
Financial Statements
Condensed Consolidated Statements of Cash Flows
Years ended June 30
2017 2016 2015
Dollars in millions 
Operating activities:
 Net earnings $  701 $  648  $  580
 Deduct: Losses from discontinued operations, net of tax  (2)  — (26)
 Earnings from continuing operations  703  648 606
 Adjustments to reconcile earnings from continuing operations to net 
  cash provided by continuing operations:
 Depreciation and amortization  163  165 169
 Stock-based compensation  51  45 32
 Deferred income taxes  (35)  5 (16)
 Settlement of interest rate forward contracts  — — (25)
 Other  36  1 (17)
 Changes in:
 Receivables, net  (1)  (52) 6
 Inventories, net  (19)  (45) (25)
 Prepaid expenses and other current assets  (5)  6 6
 Accounts payable and accrued liabilities  (34)  57 93
 Income taxes payable  12  (62) 29
Net cash provided by continuing operations  871  768 858
Net cash (used for) provided by discontinued operations  (3)  10 16
Net cash provided by operations  868  778 874
Investing activities:
 Capital expenditures  (231)  (172)  (125)
 Business acquired, net of cash acquired  — (290)  —
 Other 26 32 19
Net cash used for investing activities  (205)  (430)  (106)
Financing activities:
 Notes and loans payable, net  125  426 (48)
 Long-term debt borrowings, net of issuance costs  — — 495
 Long-term debt repayments  — (300)  (575)
 Treasury stock purchased  (183)  (254)  (434)
 Cash dividends paid  (412)  (398)  (385)
 Issuance of common stock for employee stock plans and other  75 210 251
Net cash used for financing activities  (645)  (316)  (696)
Effect of exchange rate changes on cash and cash equivalents  (1) (13) (19)
Net increase in cash and cash equivalents  17 19 53
Cash and cash equivalents:
 Beginning of year  401 382 329
 End of year $ 418 $  401  $  382
Supplemental cash flow information:
 Interest paid $ 78 $  79  $  104
 Income taxes paid, net of refunds  347 323 236
Noncash financing activities:
 Cash dividends declared and accrued, but not paid  108 104 99
 50  The Clorox Company 2017 Integrated Annual Report